U.S. federal trademark · Serial No. 90009066 · Reg. No. 6245079
Pharmaceutical products development, namely, development of pharmaceuticals in the field of oncology that target the degradation of anti-apoptotic cellular proteins
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.